menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Patient Outcomes' ×
John Procter
Medical science liaisons provide a bridge between drug development and external stakeholders, meaning they are in an ideal situation to capture valuable scientific insights.
Read More
Annette Williams
How automation and the possibilities of artificial intelligence can revolutionize pharmacovigilance.
Read More
NancyDreyer
How pragmatic clinical trials (PCTs) increase the robustness of real world studies at a fraction of the cost of classical randomized controlled clinical trials (RCTs).
Read More
David Cameron
Peter Rutherford
As cancer care becomes more complex, oncologists need support to enable them to choose the right medications and pass the information on to patients and their carers.
Read More
Annette Williams
How automation, harmonization and outsourcing are changing the way the industry conducts pharmacovigilance.
Read More
Paul Harney
How an integrated approach to engagement eliminates friction and helps patients embrace their care.
Read More
Becky Galbraith
Other forms of engagement between nurses and patients amplifies and extends the nurse's support and keeps the idea of learning about their disease foremost in patients' minds.
Read More
Barbara Klimas
Continuous Glucose Monitoring provides a balance to the A1c biomarker, providing thousands of data points to help improve diabetes treatment.
Read More
Francine Cabrera
One diabetes educator’s perspective on how her work contributes to developing additional diabetes treatment and care options.
Read More